PEPT ETF — REX ETF Trust - REX Peptide ETF

REX ETF Trust - REX Peptide ETF (PEPT)

Updated October 16, 2026.

PEPT is an ETF. its expense ratio is 0.65%.

The fund invests in companies involved in peptide-based therapeutics and related biotechnology development.

PEPT performance

Returns are updating. PEPT's total return appears here after the next nightly update.

PEPT key facts

Issuer

REX Shares

Asset type

ETF

Asset class

Equity

Inception date

10/14/2026

Expense ratio

0.65%

Last close

$25.23 (stale; as of 2026-10-16)

Average volume

8000.0

AUM unavailable in this published snapshot. Missing values do not mean zero or complete coverage. ?

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: REX Shares; prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

More on PEPT

• All tickers starting with P

Tagged: Healthcare, Pharmaceutical.

Frequently asked questions

More securities from REX Shares.